Delivery Order 75F40122D00006-75F40122F19002
Award Date
9/26/22
Potential Completion Date
8/29/25
Potential Value
$1.2M
Federal Agency
Food and Drug Administration
Awardee
Labstat International Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by...
The U.S. Food and Drug Administration (FDA) awarded a $437,684.94 firm fixed price delivery order to Labstat International Inc., a leading analytical testing laboratory, to provide tobacco lab analysis services. The scope includes generating and quantitating benzo[a]pyrene, tar, nicotine, and carbon monoxide from pipe tobacco mainstream smoke under a new smoking regimen. This delivery order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract...
This federal contract award to Labstat International Inc., a leading analytical testing laboratory, is for a stability study of cigarette tobacco filler on behalf of the Food and Drug Administration (FDA). The firm fixed price delivery order is valued at $112,994.60 and has a completion date of June 13, 2016. Labstat has been awarded multiple prior contracts from the FDA to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products in support...
This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
The Food and Drug Administration awarded a definitive contract valued at $1,010,475.20 to Labstat International Inc., a foreign-owned for-profit organization, to evaluate the microbial parameters of electronic nicotine delivery system e-liquids. The contract calls for the contractor to validate test methods, conduct antimicrobial effectiveness testing, and measure water activity, total aerobic counts, endotoxins, glucans, and nitrosamines in laboratory-prepared and commercial e-liquid samples...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Research Triangle Institute (RTI) International, a non-profit research organization, under the Engineering Analysis Laboratory Services contract vehicle. The order, valued at $237,491.59, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract is not set aside for...
This is a $274,318.10 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to GD USA Inc., a foreign-owned, for-profit, woman-owned manufacturer of specialized laboratory equipment. The contract is for the delivery of a LINEAR SMOKING MACHINE, which is a critical piece of scientific instrumentation used by the FDA's Center for Tobacco Products to support its regulatory oversight and public health research missions. The contract has no set-aside...
This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for $679,680.00. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Under this task order, LBERI will conduct an assessment of tobacco products and tobacco product constituents' genetic toxicology using in vitro assays to compare the...
This is a delivery order awarded to Data Quality Science, LLC, a small business based in Catonsville, Maryland, under an existing $35 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Food and Drug Administration (FDA). The order, valued at $178,122.92, is for tobacco retailer inspection services in the FDA's Region 4, which covers multiple western states and Puerto Rico. These services support the FDA's regulatory and enforcement activities related to tobacco product...